Patient designed therapy provides possible “natural” selection evidence for testosterone as differentiating agent for high-grade prostate cancer
| Autor: | Shaw, G.L., Emberton, M.E., Morgan, R., Berney, D., Cuzick, J., Oliver, R.T.D. |
|---|---|
| Zdroj: | In British Journal of Medical and Surgical Urology 2009 2(4):171-173 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|